Fifteen corticosteroid-treated , mild to moderate persistent asthmatics received montelukast 10 mg once daily or formoterol 9 micro g twice daily for 2 weeks , separated by a 2-week placebo run-in and washout , in a double-blind , double-dummy , randomized crossover design .
